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Left Subclavian Artery Coverage During Endovascular
Thoracic Aortic Repair and Risk of Perioperative
Stroke or Death
Matthew A. Corriere, Jayer Chung, Karthikeshwar Kasira-
jan, Ravi Veeraswamy, Thomas F. Dodson, Atef A. Salam,
Elliot L. Chaikof. Surgery, Division of Vascular Surgery
and Endovascular Therapy, Emory University School of
Medicine, Atlanta, GA
Objectives: Anatomic factors may dictate left subclavian
artery (LSA) coverage during endovascular thoracic aortic
repair (TEVAR); associations between LSA coverage, stroke,
and death are inconsistent in published reports. We examined
the 2005-2008 ACS-NSQIP data file to determine perioper-
ative risk of stroke or death after LSA coverage.
Methods: TEVAR procedures, LSA coverage, and
subclavian revascularization were identified by CPT codes.
Patients with simultaneous coronary, ascending or abdom-
inal aortic, or non-vascular abdominal procedures were
excluded. Associations between LSA coverage and 30-day
stroke and mortality were examined with logistic regres-
sion. Effects of subclavian revascularization with LSA cov-
erage were assessed with Fisher’s exact test.
Results: From 862 identified TEVAR procedures, 53
patients were excluded and 809 formed the basis of this
analysis. 279 procedures (38%) included LSA coverage;
subclavian revascularization was performed in 53 (7%).
30-day stroke and mortality rates were 5.2% and 7.1%. In
multivariate models, LSA coverage was associated with
perioperative stroke (OR 2.4; 95% CI 1.2-4.5; p  0.009)
and death (OR 1.9; 95% CI 1.0-3.6; p  0.042). Subcla-
vian revascularization was not associated with decreased
stroke or mortality in patients undergoing LSA coverage.
Conclusions: LSA coverage is associated with in-
creased risk of perioperative stroke and death; no protective
subclavian revascularization effect was observed.
Multivariate predictors of stroke and mortality.
Univariate p  0.10 for all displayed covariates.
Outcome Covariate OR (95% CI) P
Stroke Emergent procedure 3.10 (1.46-6.58) 0.003
Left subclavian artery coverage 2.36 (1.24-4.49) 0.009
Mortality Age (years) 1.46 (1.02-2.10) 0.041
WBC (1000/mL3) 1.35 (1.04-1.74) 0.024
Emergent procedure 2.23 (1.08-4.58) 0.030
Units PRBC transfused 1.26 (1.15-1.38) 0.001
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Sideways Movement of the Endograft Within the An-
eurysm Sac Is Associated With Late Adverse Events
Evert Waasdorp2, Madhu Gorrepati1, Frans Moll2, Chris-
topher Zarins1. 1Vascular Surgery, Stanford University
Medical Hospital, Stanford, CA; 2University Medical Cen-
ter Utrecht, Utrecht, Netherlands.
Objectives: Previous studies have shown the impor-
tance of proximal and distal endograft fixation. There is
little information on the middle, unsupported section of
the endograft. We have quantified sideways movement of
the endograft within the AAA sac and correlated it to late
adverse events.
Methods: Patients who underwent EVAR between
January 1997 and December 2007 were analyzed. Patients
with a digital available preoperative CT-angiography
(CTA), postoperative CTA and at least one follow-up CTA
thereafter were included. Changes in endograft position
within the AAA sac were measured. Patients with sideways
movement 5mm were placed in the movement group
(MG) and were compared with patients with no movement
(5mm, NM group). To analyze the association of side-
ways endograft movement and EVAR related complication
the following outcomemeasures were noted: AAA rupture,
AAA-related death, conversion, secondary procedures,
AAA growth (5mm), proximal migration (10mm), and
new onset type 1/3 endoleaks.
Results: 144 patients (mean age 76 year) were
included. Follow-up was 43  27 months. Fifty patients
(35%) had sideways endograft movement. AAA diameter
(MG 60  9 vs NM 57  9mm, p  0.05), and proximal
and iliac endograft fixation lengths were significantly differ-
ent between the groups (MG 18  8 vs NM 25  11mm,
p 0.05 and MG 35 15 vs NM 42 16mm, p 0.05).
There was no significant difference between the groups in
terms of AAA rupture and AAA-related death (one fatal
AAA rupture, NM group). Patients in the MG group had a
significantly higher conversion rate (14 vs 0%, p  0.001)
and had more secondary procedures (44 vs 6%, p 0.001).
Patients in the MG had significantly more AAA growth (42
vs 10%, p  0.001), more proximal migration (66 vs 5%,
p  0.001) and more often type 1/3 endoleaks (36 vs 3%,
p  0.001).
Conclusions: Sideways movement of the device within
the AAA sac is associated with late adverse events. Con-
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success.
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Continued Favorable Results With Type IV Thoraco-
abdominal Aortic Aneurysm Repair
Virendra I. Patel, Emel Ergul, Mark F. Conrad, Matthew
Cambria, Vikram Paruchuri, Glenn M. LaMuraglia, Chris-
topher J. Kwolek, David C. Brewster, Richard P. Cambria.
Vascular and Endovascular Surgery, Massachusetts General
Hospital, Boston, MA
Objectives:Type IV (T4) thoracoabdominal aneurysm
repair despite low risk of spinal cord ischemia (SCI) is
reported to have significant morbidity and mortality. This
study evaluated clinical outcomes to identify predictors of
major morbidity in T4 repair.
Methods: All T4 repairs at MGH from 1/89 - 9/09
were evaluated with respect to clinical features, technical
operative details and 30-day outcomes. Logistic regression
identified predictors of morbidity and survival was assessed
using Kaplan-Meier.
Results: 179 patients underwent T4 repair with elec-
tive repair in 156 (87%) and urgent in 23 (13%). All
operations were conducted with clamp/sew technique and
routine hypothermic renal perfusion. Clinical features were
age 73 8, male 113 (63%), prior CVA 23 (13%), CAD 90
(50%) and Cr 1.8 (CRI) 26 (15%). Aneurysm (size 6.2
1.1cm) pathology was degenerative in 174 (97%). Opera-
tive reconstruction consisted of a beveled proximal anasto-
mosis incorporating the celiac, SMA, and right renal arter-
ies origins (visceral clamp 35 11min) and a side-arm graft
to the left renal artery in 166 (93%). Technical details
included previous AAA repair in 52 (29%), OR time 290
90min, EBL 2.4 1.4l and splenectomy 56 (31%). 30-day
outcomes were mortality 5 (2.8%), MI 5 (2.8%), pulmo-
nary 30 (17%), any renal comp. 36 (20%), hemodialysis 5
(2.8%) and SCI 4 (2.2%). Univariate predictors of compli-
cations included eGFR (p  0.02) and CRI (p  0.02),
while CVA (p  0.02), visceral clamp time (p  0.04) and
any complication (p  0.01) predicted 30-day mortality.
History of CRI independently predicted postoperative
complication or death (OR 3.0 [95% CI: 1.6-8.8]). One-,
five- and ten-year survival rates were 89 2%, 64 4% and
35  5%, respectively. Post-operative SCI increased long-
term mortality (OR 17 [95% CI: 3.6-83]).
Conclusions: T4 TAA repair is associated with favor-
able perioperative results. The evident significance of CRI
should figure prominently in clinical decision making. Pa-
tients who survive the physiologic stresses of repair have
favorable long-term survival.
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Compared With Open Surgical Repair (OSR) in a High
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Sherif Sultan1, Niamh Hynes2. 1Vascular & Endovascular
Surgery, Western Vascular Institute, Galway, Ireland; 2Gal-
way Clinic, Galway, Ireland
Objectives: Although EVAR is reputable as affording
superior perioperative and mid-term survival than OSR,
approximately 50% of AAAs are anatomically unsuitable for
EVAR using contemporary devices. We aim to gauge ex-
tending use of current commercially-available devices for
pararenal AAAs compared to the current standard OSR.
Primary Endpoints were aneurysm related survival and cost
per Quality-Adjusted-Life Years (QALY).
Methods: From 2002-2009, 1868 patients with AAA
were seen at our unit. 118 patients had intervention for
pararenal AAAs which were reported by consultant radiol-
ogists as ‘unsuitable for EVAR’. 66 of these had OSR and
52 had PEVAR. The PEVAR group was older (74.3 years
vs 70.9 years, p  0.004) with significantly higher mean
SVS co-morbidity scores (p  0.002) and Kertai Probabil-
ity Indices (p 0.004). All procedures were done within 14
days of diagnosis. Mean aneurysm diameter was signifi-
cantly higher for PEVAR (7.9cm vs 6.2cm, p  0.002).
83% of PEVAR endografts were 36mm diameter. All OSR
were done with diagonal proximal clamp, preserving flow
to the highest renal artery. Renal arteries were re-implanted
in five cases and the IMA once
Results: 5-year aneurysm-related survival rates were
higher with PEVAR (98% vs 92.4%, P0.05), although this
did not reach statistical significance. 5-year freedom from
secondary intervention was similar between PEVAR
(88.7%) and OSR (98%, P0.05). 5-year all-cause survival
was also statistically similar (PEVAR, 44.2% vs OSR 80.4%,
p  0.155). 5-year intervention-free survival was shy of
significance with PEVAR (48.5%) vs OSR (76.8.4%, p 
0.0503). 30-day morbidity (p  0.0002), Length of hos-
pital stay (p  0.0005), 5-year Q-TWiST (p  0.01) and
cost per QALY (p  0.01) were all significantly reduced
with PEVAR vs OSR.
Conclusions: Endografts can be effectively used to
treat difficult pararenal AAAs with acceptable long-term
aneurysm-related survival and enhanced cost per QALY
and reduced perioperative morbidity, mortality and waiting
time from diagnosis to treatment.
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